ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,428.09
-0.65%
US Tech 100
18,281.60
-1.48%
Dow Jones
40,649.78
0.27%
Brent Oil
78.235
-1.15%
Bitcoin
65,829.14
-1.49%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. UK
  5. LSE

  6. Hsbc Msci Em (HMEF) Quote

Hsbc Msci Em

Hsbc Msci Em (HMEF)

LSE
830.625
-1.25
(-0.15%)
Closed July 30 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
830.625
Bid
830.25
Ask
831.00
Volume
147,645
824.375 Day's Range 841.00
0.00 52 Week Range 0.00
Market Cap
160.001B
Previous Close
831.875
Open
834.50
Last Trade
28
@
830.25
(O)
Last Trade Time
Financial Volume
1,231,580p
VWAP
834.1494
Average Volume (3m)
-
Shares Outstanding
19,262,728,000
Dividend Yield
-
PE Ratio
24.66
Earnings Per Share (EPS)
1.22
Revenue
65.91B
Net Profit
23.53B

About Hsbc Msci Em

Sector
Offices-bank Holding Company
Industry
Offices-bank Holding Company
Website
www.hsbc.com
Headquarters
London, Gbr
Founded
1970
Hsbc Msci Em is listed in the Offices-bank Holding Company sector of the London Stock Exchange with ticker HMEF. The last closing price for Hsbc Msci Em was 831.88p. Over the last year, Hsbc Msci Em shares have traded in a share price range of 0.00p to 0.00p.

Hsbc Msci Em currently has 19,262,728,000 shares outstanding. The market capitalization of Hsbc Msci Em is £160.24 billion. Hsbc Msci Em has a price to earnings ratio (PE ratio) of 24.66.

HMEF Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

June 14 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 03 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IMNNImunon Inc
$ 2.9661
(149.25%)
119.17M
ATPCAgape ATP Corporation
$ 0.166
(89.71%)
185.74M
ISPOInspirato Inc
$ 8.05
(53.63%)
25.33M
BFIBurgerFi International Inc
$ 0.6151
(30.76%)
18.52M
PHARPharming Group NV
$ 8.75
(28.30%)
50.7k
QXOQXO Inc
$ 12.10
(-80.00%)
15.54M
VBIVVBI Vaccines Inc
$ 0.1165
(-79.06%)
11.06M
BIMIBIMI International Medical Inc
$ 0.3881
(-66.54%)
2.13M
CNSPCNS Pharmaceuticals Inc
$ 0.4214
(-59.48%)
43.57M
BLMZBloomZ Inc
$ 1.62
(-36.96%)
552.99k
NVDANVIDIA Corporation
$ 105.29
(-5.65%)
304.57M
ATPCAgape ATP Corporation
$ 0.166
(89.71%)
185.75M
SQQQProShares UltraPro Short QQQ
$ 9.4899
(4.86%)
134.57M
IMNNImunon Inc
$ 2.96
(148.74%)
119.17M
TSLATesla Inc
$ 223.24
(-3.82%)
70.18M

Discussion

View Full Feed
miltong miltong 3 minutes ago
dstock, I have to admire you for your endless DD. But also I can't help it but to remind you that you've an "IGNORE" button.
NWBO
jedijazz jedijazz 3 minutes ago
$NRXP - Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) https://www.einpresswire.com/article/731567953/alignment-with-fda-on-pediatric-study-plan-and-accelerated-approval-to-treat-bipolar-depress
NRXP
chainma1l chainma1l 3 minutes ago
Hello? This amazing project was supposed to be completed by the end of September 2023, so that is definitely NOT nothing. Of course that was last year.
Viper Networks and ‘House of Invention’ Announce Smart Cities Partnership Agreement for Immediate Project in the Kingdom of Saudi Arabia
VPER
jedijazz jedijazz 3 minutes ago
$NRXP - Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) https://www.einpresswire.com/article/731567953/alignment-with-fda-on-pediatric-study-plan-and-accelerated-approval-to-treat-bipolar-depress
NRXP
Buckey Buckey 3 minutes ago
SLNAF now trading at .0006 but such low volume it is unlikely any money making opps were presented with a grey sheet no visible bid or ask
SLNAF
Monroe1 Monroe1 3 minutes ago
https://med.stanford.edu/news/all-news/2024/06/paxlovid-covid.html

https://www.ucsf.edu/news/2024/01/426906/study-finds-paxlovid-treatment-does-not-reduce-risk-long-covid

Many doctors don't prescribe it because of it's interactions with other medication.

PFE
janetcanada janetcanada 3 minutes ago
👀***HIRU- Quote: "Posted by a "trader" claiming to be down 50% in a 3 week 1000% RUN UP !!......

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/HIRU/overview

👀***Insider Trading Screener- Enter Symbol....


HIRU
Jahvik Jahvik 4 minutes ago
https://x.com/authentichldgs/status/1818305619335536657?s=42
AHRO
tick talk tick talk 4 minutes ago
Is he a liar, or are u? Go gncp$$$
GNCP
Azart Azart 4 minutes ago
It will never happen for common holders here. NEVER! CEO Scamus looking is too much of a POS to allow you the common eat on his time.
RNVA
jimmybob jimmybob 4 minutes ago
https://x.com/OMillionaires/status/1818343688864399864
Monksdream Monksdream 4 minutes ago
EVOK new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/30/bc[rsIMG_0148.gif
EVOK
sab63090 sab63090 4 minutes ago
If the 2019 Filing has expired, it would not make sense to have done a new filing? I'm confused....
AVXL
work-n-hard work-n-hard 4 minutes ago
Doubled up @ .7128 Avg. now .7814
SGMO
manibiotech manibiotech 4 minutes ago
Time for another big biz show ? Or maybe start YouTube channel this time
NWBO
trading.jeff trading.jeff 5 minutes ago
Powell could stir things up. haha
Jasbg Jasbg 5 minutes ago
Sleven, Thanks for posting (finding) this link. First official information on BRAVE Study for a long time.
AMRN
I-Glow I-Glow 5 minutes ago
You obviously are clueless about shorting OTC stocks.

You can't short a stock that has unsolicited quotes only.

MMs do not "short" penny stocks. As part of making a market, they may have periodic short positions throughout a trading day if they fill buy orders for more
SPZI
dennisdave dennisdave 5 minutes ago
Not if approval comes in a vacuum with no other news.

If approval is the next news we get, it's going to disappoint a lot of people.

Got to have a path forward or investors won't be interested.
100% agree
NWBO
Tom turtles Tom turtles 5 minutes ago
Fuc k November...and F uck Sima
JAGX
WinstonCup WinstonCup 5 minutes ago
We are in the same boat! I hope WDLF succeds, more sooner than later. I am just stating what has been posted by other members on this board, not criticing at. At the same keeping Ken accountable. Sorry if it upsets you. I guess you can always put me on ignore if it bothers you that much.
WDLF
seve333 seve333 5 minutes ago
probabably 10 a share max on a bo.
AMRN
Tree Tree 5 minutes ago
No. I am seeing them at a Casino
Filterthenoise Filterthenoise 5 minutes ago
I hope they rip us outta EM in grand fashion$RNVA
RNVA
tradernewstip tradernewstip 6 minutes ago
$CBDW 1606 Corp: A Strategic Player in AI

1606 Corp is emerging as a key player in this burgeoning market. The company’s strategic initiatives and innovative approach position it well to capitalize on the AI revolution. 1606 Corp’s commitment to leveraging AI to develop cutting-edge s
CBDW

Your Recent History

LSE
HMEF
Hsbc Msci Em
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved